Correlation Between Apellis Pharmaceuticals and Atara Biotherapeutics
Can any of the company-specific risk be diversified away by investing in both Apellis Pharmaceuticals and Atara Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Apellis Pharmaceuticals and Atara Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Apellis Pharmaceuticals and Atara Biotherapeutics, you can compare the effects of market volatilities on Apellis Pharmaceuticals and Atara Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Apellis Pharmaceuticals with a short position of Atara Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Apellis Pharmaceuticals and Atara Biotherapeutics.
Diversification Opportunities for Apellis Pharmaceuticals and Atara Biotherapeutics
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Apellis and Atara is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Apellis Pharmaceuticals and Atara Biotherapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Atara Biotherapeutics and Apellis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Apellis Pharmaceuticals are associated (or correlated) with Atara Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Atara Biotherapeutics has no effect on the direction of Apellis Pharmaceuticals i.e., Apellis Pharmaceuticals and Atara Biotherapeutics go up and down completely randomly.
Pair Corralation between Apellis Pharmaceuticals and Atara Biotherapeutics
Given the investment horizon of 90 days Apellis Pharmaceuticals is expected to generate 0.56 times more return on investment than Atara Biotherapeutics. However, Apellis Pharmaceuticals is 1.78 times less risky than Atara Biotherapeutics. It trades about 0.01 of its potential returns per unit of risk. Atara Biotherapeutics is currently generating about -0.01 per unit of risk. If you would invest 5,036 in Apellis Pharmaceuticals on August 29, 2024 and sell it today you would lose (1,622) from holding Apellis Pharmaceuticals or give up 32.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Apellis Pharmaceuticals vs. Atara Biotherapeutics
Performance |
| Timeline |
| Apellis Pharmaceuticals |
| Atara Biotherapeutics |
Apellis Pharmaceuticals and Atara Biotherapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Apellis Pharmaceuticals and Atara Biotherapeutics
The main advantage of trading using opposite Apellis Pharmaceuticals and Atara Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Apellis Pharmaceuticals position performs unexpectedly, Atara Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atara Biotherapeutics will offset losses from the drop in Atara Biotherapeutics' long position.| Apellis Pharmaceuticals vs. Bright Minds Biosciences | Apellis Pharmaceuticals vs. HP Inc | Apellis Pharmaceuticals vs. Intel | Apellis Pharmaceuticals vs. Chevron Corp |
| Atara Biotherapeutics vs. Fate Therapeutics | Atara Biotherapeutics vs. Sana Biotechnology | Atara Biotherapeutics vs. Caribou Biosciences | Atara Biotherapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Complementary Tools
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |